Wire by Fusion42
Fusion42 Scout Raise
The Debrief & Outliers
Regulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers
Benchmarks
Benchmarks HomeBy News TypeBy RegionBy Sector
AI WeeklyAbout

Switch product

Fusion42RaiseScoutWire

The Debrief & Outliers

All editionsRegulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers

Database & benchmarks

Benchmarks HomeBy News TypeBy RegionBy SectorStories

Account

Sign in
← Back

Wire · operational-macro

CMS issues formal notice of faster approval for breakthrough medical devices

10 August 2026 · By · Wire by Fusion42

Published

10 August 2026

Topic

operational-macro

◆ Sectors

Medtech

◆ Geography

United States

◆ Source

Read at healthcarefinancenews.com →

◆ Verified

Fusion42 · 25 August 2026 · Fusion42 review

CMS has issued a proposed procedural notice for the RAPID coverage pathway, allowing faster Medicare coverage decisions for FDA-designated breakthrough medical devices to align with FDA market authorizations, with coverage potentially starting 60 days post-authorization.

This Wire brief sits within Fusion42's coverage of Medtech, and 4 sources have reported it between 7 Aug 2026 and 12 Aug 2026.

◆ ◆ The Wire takeaway

Your medtech device can reach Medicare patients faster with the RAPID pathway cutting delays between FDA approval and coverage. Capitalise on this more predictable route to market early to gain a competitive edge.

◆ Coverage

4 sources · first reported 7 Aug 2026 · latest 12 Aug 2026

◆ Related on Wire

◆ Topics

Medtechmedicarebreakthrough-devicesfda-alignmenthealth-regulation